References
- Aoyama H : Radiation therapy for brain metastases in breast cancer patients. Breast Cancer 18 : 244-251, 2011 https://doi.org/10.1007/s12282-010-0207-8
- Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. : Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation : a randomised controlled trial. Lancet Oncol 10 : 1037-1044, 2009 https://doi.org/10.1016/S1470-2045(09)70263-3
- Duchnowska R, Dziadziuszko R, Czartoryska-Arlukowicz B, Radecka B, Szostakiewicz B, Sosinska-Mielcarek K, et al. : Risk factors for brain relapse in HER2-positive metastatic breast cancer patients. Breast Cancer Res Treat 117 : 297-303, 2009 https://doi.org/10.1007/s10549-008-0275-z
- Eichler AF, Kuter I, Ryan P, Schapira L, Younger J, Henson JW : Survival in patients with brain metastases from breast cancer : the importance of HER-2 status. Cancer 112 : 2359-2367, 2008 https://doi.org/10.1002/cncr.23468
- Gabos Z, Sinha R, Hanson J, Chauhan N, Hugh J, Mackey JR, et al. : Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer. J Clin Oncol 24 : 5658-5663, 2006 https://doi.org/10.1200/JCO.2006.07.0250
- Golden DW, Lamborn KR, McDermott MW, Kunwar S, Wara WM, Nakamura JL, et al. : Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases : variation by primary site. J Neurosurg 109 Suppl : 77-86, 2008 https://doi.org/10.3171/JNS/2008/109/7/0077
- Goyal S, Prasad D, Harrell F Jr, Matsumoto J, Rich T, Steiner L : Gamma knife surgery for the treatment of intracranial metastases from breast cancer. J Neurosurg 103 : 218-223, 2005 https://doi.org/10.3171/jns.2005.103.2.0218
- Gu HW, Sohn MJ, Lee DJ, Lee HR, Lee CH, Whang CJ : Clinical analysis of novalis stereotactic radiosurgery for brain metastases. J Korean Neurosurg Soc 46 : 245-251, 2009 https://doi.org/10.3340/jkns.2009.46.3.245
- Le Scodan R, Massard C, Mouret-Fourme E, Guinebretierre JM, Cohen- Solal C, De Lalande B, et al. : Brain metastases from breast carcinoma : validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score. Int J Radiat Oncol Biol Phys 69 : 839-845, 2007 https://doi.org/10.1016/j.ijrobp.2007.04.024
- Lee S, Ahn HK, Park YH, Nam do H, Lee JI, Park W, et al. : Leptomeningeal metastases from breast cancer : intrinsic subtypes may affect unique clinical manifestations. Breast Cancer Res Treat 129 : 809-817, 2011 https://doi.org/10.1007/s10549-011-1682-0
- Liu MT, Hsieh CY, Wang AY, Chang TH, Pi CP, Huang CC, et al. : Prognostic factors affecting the outcome of brain metastases from breast cancer. Support Care Cancer 14 : 936-942, 2006 https://doi.org/10.1007/s00520-006-0029-6
- Matsumoto K, Ando M, Yamauchi C, Egawa C, Hamamoto Y, Kataoka M, et al. : Questionnaire survey of treatment choice for breast cancer patients with brain metastasis in Japan : results of a nationwide survey by the task force of the Japanese Breast Cancer Society. Jpn J Clin Oncol 39 : 22-26, 2009
- Monje ML, Palmer T : Radiation injury and neurogenesis. Curr Opin Neurol 16 : 129-134, 2003 https://doi.org/10.1097/00019052-200304000-00002
- Nieder C, Marienhagen K, Astner ST, Molls M : Prognostic scores in brain metastases from breast cancer. BMC Cancer 9 : 105, 2009 https://doi.org/10.1186/1471-2407-9-105
- Ono M, Ando M, Yunokawa M, Nakano E, Yonemori K, Matsumoto K, et al. : Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer. Int J Clin Oncol 14 : 48-52, 2009 https://doi.org/10.1007/s10147-008-0797-8
- Park IH, Ro J, Lee KS, Nam BH, Kwon Y, Shin KH : Trastuzumab treatment beyond brain progression in HER2-positive metastatic breast cancer. Ann Oncol 20 : 56-62, 2009
- Park YH, Park MJ, Ji SH, Yi SY, Lim DH, Nam DH, et al. : Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients. Br J Cancer 100 : 894-900, 2009 https://doi.org/10.1038/sj.bjc.6604941
- Siu TL, Jeffree RL, Fuller JW : Current strategies in the surgical management of cerebral metastases : an evidence-based review. J Clin Neurosci 18 : 1429-1434, 2011 https://doi.org/10.1016/j.jocn.2011.04.002
- Tsukada Y, Fouad A, Pickren JW, Lane WW : Central nervous system metastasis from breast carcinoma. Autopsy study. Cancer 52 : 2349- 2354, 1983 https://doi.org/10.1002/1097-0142(19831215)52:12<2349::AID-CNCR2820521231>3.0.CO;2-B
- Wolstenholme V, Hawkins M, Ashley S, Tait D, Ross G : HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients. Breast 17 : 661-665, 2008 https://doi.org/10.1016/j.breast.2008.04.006
Cited by
- Do patients with very few brain metastases from breast cancer benefit from whole-brain radiotherapy in addition to radiosurgery? vol.9, pp.None, 2013, https://doi.org/10.1186/s13014-014-0267-6
- Efficacy and Safety of Fractionated Stereotactic Radiosurgery for Large Brain Metastases vol.58, pp.3, 2013, https://doi.org/10.3340/jkns.2015.58.3.217
- The role of magnetic resonance-guided laser ablation in neurooncology vol.29, pp.2, 2013, https://doi.org/10.3109/02688697.2014.996527